NEW YORK, Oct. 24, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (OTCQB: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that its 2024 Annual Meeting of...
Seelos Announces Second Postponement of its Annual Meeting of Stockholders
Seaking AlphaSeeking Alpha / Seaking Alpha 15 hours ago 1 Views
Comments